Company intelligence / Profile preview

Stellence Pharmscience

Bangalore/Jigani, Karnataka, Indiastellence.com ↗
Ownership
Private
Employees
~32
Development stage
Other
01

Overview

As an API/intermediate supplier, Stellence Pharmscience is not directly involved in drug development or clinical trials. No direct summary of clinical results available for proprietary drugs.

Therapeutic areas
NeurologyMetabolic DisordersInfectious DiseasesOphthalmologyEndocrinologyOther
Modalities
Small moleculePeptidesAmino acids/derivativesMetal ion chelates/chelators
Industry
Chemicals & Materials
02

Partnerships

B2B partnerships with pharma companies as clients

Beyond the preview

Go deeper on Stellence Pharmscience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stellence Pharmscience.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call